RT @AmiBPatelMD: Check out our lab’s latest manuscript in @BCD_AACR! @huntsmancancer SIRT5 Is a Druggable Metabolic Vulnerability in Acut…
New 3i Investigator Article Alert!! SIRT5 Is a Druggable Metabolic Vulnerability in Acute Myeloid Leukemia https://t.co/h5Vhl3xURc #sciencetwitter #academictwitter
New article: SIRT5 Is a Druggable Metabolic Vulnerability in Acute Myeloid Leukemia https://t.co/Fhv6ax79ax #AML #leusm #hematology https://t.co/Owzpi9H1Mp
RT @RobotRrid: The authors of "SIRT5 Is a Druggable Metabolic Vulnerability in Ac…" (https://t.co/dsaqZuQjF8) included RRIDs in their paper…
The authors of "SIRT5 Is a Druggable Metabolic Vulnerability in Ac…" (https://t.co/dsaqZuQjF8) included RRIDs in their paper! Thank you for making your #methodsmatter. #OpenScience
ICYMI: SIRT5 Is a Druggable Metabolic Vulnerability in Acute Myeloid Leukemia https://t.co/HY8NDyJjNq
RT @AmiBPatelMD: Check out our lab’s latest manuscript in @BCD_AACR! @huntsmancancer SIRT5 Is a Druggable Metabolic Vulnerability in Acut…
RT @AmiBPatelMD: Check out our lab’s latest manuscript in @BCD_AACR! @huntsmancancer SIRT5 Is a Druggable Metabolic Vulnerability in Acut…
RT @AmiBPatelMD: Check out our lab’s latest manuscript in @BCD_AACR! @huntsmancancer SIRT5 Is a Druggable Metabolic Vulnerability in Acut…
RT @AmiBPatelMD: Check out our lab’s latest manuscript in @BCD_AACR! @huntsmancancer SIRT5 Is a Druggable Metabolic Vulnerability in Acut…
RT @AmiBPatelMD: Check out our lab’s latest manuscript in @BCD_AACR! @huntsmancancer SIRT5 Is a Druggable Metabolic Vulnerability in Acut…
Check out our lab’s latest manuscript in @BCD_AACR! @huntsmancancer SIRT5 Is a Druggable Metabolic Vulnerability in Acute Myeloid Leukemia https://t.co/GQ27ChjCb5
RRIDs were included in the Blood Cancer Discovery paper "SIRT5 IS A DRUGGABLE METABOLIC VULNERABILITY IN AC…" (https://t.co/pSC0DDDKBE). RRIDs like this improve reproducibility in scientific research. #reproducibility #RRID
RT @UofU3i: New 3i Investigator Article Alert!! SIRT5 IS A DRUGGABLE METABOLIC VULNERABILITY IN ACUTE MYELOID LEUKEMIA https://t.co/N6S6fA…
#ICYMI: SIRT5 is a druggable metabolic vulnerability in acute myeloid #leukemia. @huntsmancancer https://t.co/oiFIHTm19t https://t.co/QSxFiDl7pT
RT @UofU3i: New 3i Investigator Article Alert!! SIRT5 IS A DRUGGABLE METABOLIC VULNERABILITY IN ACUTE MYELOID LEUKEMIA https://t.co/N6S6fA…
New 3i Investigator Article Alert!! SIRT5 IS A DRUGGABLE METABOLIC VULNERABILITY IN ACUTE MYELOID LEUKEMIA https://t.co/N6S6fABMsj #sciencetwitter #academictwitter
New article: SIRT5 IS A DRUGGABLE METABOLIC VULNERABILITY IN ACUTE MYELOID LEUKEMIA https://t.co/w3O1XnPAjw #AML #leusm #hematology https://t.co/rohobwIu5z
#ICYMI: SIRT5 is a druggable metabolic vulnerability in acute myeloid #leukemia. @huntsmancancer https://t.co/tUiGO2fq80 https://t.co/XMnqQlc4Uz
From the May issue: SIRT5 is a druggable metabolic vulnerability in acute myeloid #leukemia. @huntsmancancer https://t.co/9wxbrXJUEo https://t.co/7gC38P8NMt
RT @dalessandrolab: Congratulations to the Deininger lab for this exciting story! SIRT5 Is a Druggable Metabolic Vulnerability in Acute Mye…
RT @dalessandrolab: Congratulations to the Deininger lab for this exciting story! SIRT5 Is a Druggable Metabolic Vulnerability in Acute Mye…
Congratulations to the Deininger lab for this exciting story! SIRT5 Is a Druggable Metabolic Vulnerability in Acute Myeloid Leukemia https://t.co/K1WLyJVFwV
RT @_TanyaBondar_: Just published @BCD_AACR concurrent with Dongqing Yan's #AACR21 presentation LB109: SIRT5 Is a Druggable Metabolic Vulne…
And here is the link for the full article: https://t.co/XfJ5HjxM3u
Simultaneous publication with Dongqing Yan's #AACR21 presentation: SIRT5 is a druggable metabolic vulnerability in acute myeloid #leukemia. @huntsmancancer https://t.co/Tjk9bzbfza https://t.co/vkSWJpSc5p
Just published @BCD_AACR concurrent with Dongqing Yan's #AACR21 presentation LB109: SIRT5 Is a Druggable Metabolic Vulnerability in Acute #Myeloid #Leukemia @huntsmancancer #leusm https://t.co/spduymqNzA https://t.co/nkQ3GDcVGx